Skip to content
R

Raymond Chibvongodze

0000-0002-6442-3323

Publications (3)

Triaging Women with Prior ASCUS Liquid Based Cytology (LBC) Results with Hr-HPV DNA Testing in Harare, Zimbabwe

Raymond Chibvongodze, Tafadzwa Dupwa, Lucy Muchiri & Chantal Nyirakanani · International Research Journal of Oncology · 2021

Background: ASCUS is a borderline cytopathological diagnostic category that leaves clinicians with a dilemma regarding how to manage the patient. Triaging women with prior ASCUS results with Hr-HPV testing helps to distinguish those with true neoplastic lesions from those with re...

Open access Research Article

The Clinical Value of Screening for Cervical Cancer using the High Risk Human Papilloma Virus (HR-HPV) and Liquid Based Cytology (LBC) Co-Testing Approach Compared to Screening with Individual Tests in Harare, Zimbabwe

Raymond Chibvongodze, Tafadzwa Dupwa, Elson Mberi, Chantal Nyirakanani & Lucy Wangari Muchiri · Asian Research Journal of Gynaecology and Obstetrics · 2021

Background: Cervical cancer is the most common malignancy in Zimbabwe. This attributed  to poorly executed Pap smear based screening programs. Pap smears have poor sensitivity and high specificity while HR-HPV DNA testing has high sensitivity and poor specificity. With reference...

Open access Research Article

High Risk Human Papillomavirus (Hr-HPV) Prevalence and Genotypes Detected in Women ≥ 30 Years Old who have Never been Screened for Cervical Cancer in Harare, Zimbabwe

Raymond Chibvongodze, Tafadzwa Dupwa, Elson Mberi, Chantal Nyirakanani & Lucy Wangari Muchiri · Asian Research Journal of Gynaecology and Obstetrics · 2021

Background: Almost 50% of all cervical cancer cases are diagnosed in patients who have never been screened for cervical cancer before. There is an established cause - effect relationship between Hr-HPV infection and cervical cancer. Therefore, knowing the prevalence and high risk...

Open access Research Article